Related references
Note: Only part of the references are listed.The emergence of clinical resistance to tigecycline
Yan Sun et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Mutant prevention concentration of colistin alone and in combination with levofloxacin or tobramycin against multidrug-resistant Acinetobacter baumannii
Yun Cai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates
Aydin Deveci et al.
JOURNAL OF CHEMOTHERAPY (2012)
In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates
Kyong Ran Peck et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
Doo Ryeon Chung et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Single-Agent, Broad-Spectrum Fluoroquinolones for the Outpatient Treatment of Low-Risk Febrile Neutropenia
Maryann R. Cooper et al.
ANNALS OF PHARMACOTHERAPY (2011)
Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens
Shio-Shin Jean et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
In Vitro Antimicrobial Activity and Mutant Prevention Concentration of Colistin against Acinetobacter baumannii
Yun Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii
Jun-Chang Cui et al.
JOURNAL OF ANTIBIOTICS (2010)
In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii
Murat Dizbay et al.
JOURNAL OF ANTIBIOTICS (2010)
Serum Bactericidal Activity of Three Different Dosing Regimens of Colistin with Implications for Optimum Clinical Use
G. L. Daikos et al.
JOURNAL OF CHEMOTHERAPY (2010)
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies
J. M. Entenza et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline
Kara B. Anthony et al.
CLINICAL INFECTIOUS DISEASES (2008)
Acinetobacter balumannii:: an emerging multidrug-resistant threat
Thomas D. Gootz et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy
Joshua S. Hawley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea
Kwan Soo Ko et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa
George G. Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The mutant selection window and antimicrobial resistance
K Drlica
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Restricting the selection of antibiotic-resistant mutants: A general strategy derived from fluoroquinolone studies
XL Zhao et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
